Get Premium to unlock powerful stock data
NAS:UROV (UK)  
Urovant Sciences Ltd logo

Urovant Sciences Ltd

$ 16.24 0 (0%) 09:40 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 531.75M
Enterprise V:
$ 531.75M
Volume:
-
Avg Vol (2M):
-
Volume:
-
Market Cap $:
531.75M
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value $:
531.75M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Urovant Sciences Ltd
NAICS : 325412 SIC : 2834
11-12 St. James’s Square, Suite 1, 3rd Floor, London, GBR, SW1Y 4LB
Description
Urovant Sciences Ltd is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing therapies for urologic conditions. The company's pipeline products include Overactive Bladder (OAB), OAB in Men with Benign Prostatic Hyperplasia (BPH), and IBS-Associated Pain.

Financial Strength

Name Current Vs Industry Vs History
Piotroski F-Score 0/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % 75.95
12-1 Month Momentum % 62.19

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-13 Est.)

UROV's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:UROV

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -5.25
Beta 0
Volatility % 68.37
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % 62.19
52-Week Range ($) 7.15 - 16.26
Shares Outstanding (Mil) 32.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Urovant Sciences Ltd Filings

Document Form Filing Date
No Filing Data

Headlines

See More